Search research articles
Contact Us
Filters
Showing results (761-770 of 796) with videos related to
Page
of 80
Sort By:
Journal of Medicinal Chemistry
|
June 25, 2004
Synthesis and biological evaluation of 3-heterocyclyl-7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines and analogues as subtype-selective inverse agonists for the GABA(A)alpha5 benzodiazepine binding site
Leslie J Street, Francine Sternfeld, Richard A Jelley, et al.
Journal of Medicinal Chemistry
|
November 11, 2005
7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine: a functionally selective gamma-aminobutyric acid(A) (GABA(A)) alpha2/alpha3-subtype selective agonist that exhibits potent anxiolytic activity but is not sedating in animal models
Robert W Carling, Andrew Madin, Alec Guiblin, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
June 23, 2024
Social dysfunction relates to shifts within socioaffective brain systems among Schizophrenia and Alzheimer's disease patients
Simon Braak, Brenda Wjh Penninx, Tanja Su, et al.
Neuroscience Applied
|
August 21, 2025
Using the grip strength effort task to measure reward processing dysfunction in schizophrenia and major depressive disorder
Asad Malik, Shannon N Millard, Ailidh Finlayson, et al.
Space Science Reviews
|
November 24, 2025
Europa Clipper Magnetometer Boom Deployment: A First Look at the Magnetometer Observations of the Spacecraft and the Interplanetary Magnetic Field
Corey J Cochrane, Steven P Joy, Haje Korth, et al.
Nature Neuroscience
|
May 18, 2000
Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype
R M McKernan, T W Rosahl, D S Reynolds, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 27, 2021
The clinical effectiveness of using a predictive algorithm to guide antidepressant treatment in primary care (PReDicT): an open-label, randomised controlled trial
Michael Browning, Amy C Bilderbeck, Rebecca Dias, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 18, 2005
Evidence for a significant role of alpha 3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines
Rebecca Dias, Wayne F A Sheppard, Rosa L Fradley, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
October 31, 2021
Relationships between social withdrawal and facial emotion recognition in neuropsychiatric disorders
Alejandro de la Torre-Luque, Alba Viera-Campos, Amy C Bilderbeck, et al.
Journal of Psychopharmacology (Oxford, England)
|
February 17, 2010
Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist
J R Atack, D J Hallett, S Tye, et al.
Page
of 80
Search research articles
Search
Showing results (761-770 of 796) with videos related to
Sort By:
Page
of 80
Journal of Medicinal Chemistry
|
June 25, 2004
Synthesis and biological evaluation of 3-heterocyclyl-7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines and analogues as subtype-selective inverse agonists for the GABA(A)alpha5 benzodiazepine binding site
Leslie J Street, Francine Sternfeld, Richard A Jelley, et al.
Journal of Medicinal Chemistry
|
November 11, 2005
7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine: a functionally selective gamma-aminobutyric acid(A) (GABA(A)) alpha2/alpha3-subtype selective agonist that exhibits potent anxiolytic activity but is not sedating in animal models
Robert W Carling, Andrew Madin, Alec Guiblin, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
June 23, 2024
Social dysfunction relates to shifts within socioaffective brain systems among Schizophrenia and Alzheimer's disease patients
Simon Braak, Brenda Wjh Penninx, Tanja Su, et al.
Neuroscience Applied
|
August 21, 2025
Using the grip strength effort task to measure reward processing dysfunction in schizophrenia and major depressive disorder
Asad Malik, Shannon N Millard, Ailidh Finlayson, et al.
Space Science Reviews
|
November 24, 2025
Europa Clipper Magnetometer Boom Deployment: A First Look at the Magnetometer Observations of the Spacecraft and the Interplanetary Magnetic Field
Corey J Cochrane, Steven P Joy, Haje Korth, et al.
Nature Neuroscience
|
May 18, 2000
Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype
R M McKernan, T W Rosahl, D S Reynolds, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 27, 2021
The clinical effectiveness of using a predictive algorithm to guide antidepressant treatment in primary care (PReDicT): an open-label, randomised controlled trial
Michael Browning, Amy C Bilderbeck, Rebecca Dias, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 18, 2005
Evidence for a significant role of alpha 3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines
Rebecca Dias, Wayne F A Sheppard, Rosa L Fradley, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
October 31, 2021
Relationships between social withdrawal and facial emotion recognition in neuropsychiatric disorders
Alejandro de la Torre-Luque, Alba Viera-Campos, Amy C Bilderbeck, et al.
Journal of Psychopharmacology (Oxford, England)
|
February 17, 2010
Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist
J R Atack, D J Hallett, S Tye, et al.
Page
of 80